PFKP and adrenal cortex carcinoma: As log-rank test overall survival (OS) analysis (Fig. 3) shown, patients with higher expression of PFKP had a worse OS in ACC (p = 0.0013), BLCA (p = 0.00091), BRCA (p = 0.0085), CESC (p = 0.0029), HNSC (p < 0.0001), KICH (p = 0.01), LAML (p = 0.016), LIHC (p < 0.0001), LUAD (p = 0.00012), MESO (p = 0.0067), PAAD (p = 0.033), SKCM (p = 0.017), and UVM (p < 0.0001).